Profarma Distribuidora de Produtos Farmacêuticos S.A (SA:PFRM3) — Stock Price
Profarma Distribuidora de Produtos Farmacêuticos S.A (SA:PFRM3) is currently trading at R$7.01 BRL, down 0.57% today. Over the past 52 weeks, shares have ranged between R$6.16 and R$9.38. This page tracks Profarma Distribuidora de Produtos Farmacêuticos S.A's live share price on the SA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Profarma Distribuidora de Produtos Farma worth.
Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Profarma Distribuidora de Produtos Farmacêuticos S.A's daily closing share price and trading volume on the SA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Profarma Distribuidora de Produtos Farmacêuticos S.A Income Statement — Revenue, Profit & Earnings by Year
Profarma Distribuidora de Produtos Farmacêuticos S.A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | R$10.15 Billion | R$8.66 Billion | R$7.82 Billion | R$6.41 Billion | R$5.48 Billion |
| Cost of Revenue | R$8.63 Billion | R$7.37 Billion | R$6.67 Billion | R$5.51 Billion | R$4.72 Billion |
| Gross Profit | R$1.52 Billion | R$1.29 Billion | R$1.15 Billion | R$907.57 Million | R$763.57 Million |
| Research & Development | — | — | — | — | — |
| SG&A | R$302.88 Million | R$242.84 Million | R$25.12 Million | R$140.07 Million | R$120.92 Million |
| Total Operating Expenses | R$1.27 Billion | R$1.05 Billion | R$916.83 Million | R$666.59 Million | R$568.40 Million |
| Operating Income | R$254.34 Million | R$245.62 Million | R$228.68 Million | R$100.39 Million | R$97.22 Million |
| EBITDA | R$401.46 Million | R$353.37 Million | R$380.44 Million | R$226.44 Million | R$182.99 Million |
| EBIT | R$231.94 Million | R$204.85 Million | R$242.22 Million | R$100.56 Million | R$81.05 Million |
| Interest Expense | R$161.41 Million | R$168.31 Million | R$163.24 Million | R$82.04 Million | R$68.28 Million |
| Income Before Tax | R$127.86 Million | R$81.59 Million | R$78.97 Million | R$48.75 Million | R$33.15 Million |
| Income Tax Expense | R$5.05 Million | R$3.73 Million | R$-6.07 Million | R$-30.37 Million | R$-28.65 Million |
| Net Income | R$114.58 Million | R$70.40 Million | R$80.87 Million | R$78.19 Million | R$52.33 Million |
Profarma Distribuidora de Produtos Farmacêuticos S.A Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Profarma Distribuidora de Produtos Farmacêuticos S.A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | R$5.62 Billion | R$4.94 Billion | R$4.36 Billion | R$4.03 Billion | R$3.76 Billion |
| Total Current Assets | R$4.02 Billion | R$3.54 Billion | R$2.98 Billion | R$2.58 Billion | R$2.48 Billion |
| Cash & Equivalents | R$224.22 Million | R$186.75 Million | R$173.92 Million | R$139.49 Million | R$342.77 Million |
| Short-term Investments | R$9.50 Million | R$0.00 | R$-44.65 Million | R$4.66 Million | R$23.06 Million |
| Net Receivables | R$1.47 Billion | R$1.33 Billion | R$1.12 Billion | R$911.73 Million | R$829.59 Million |
| Inventory | R$1.82 Billion | R$1.53 Billion | R$1.24 Billion | R$1.08 Billion | R$903.84 Million |
| Property, Plant & Equipment | R$674.18 Million | R$535.59 Million | R$507.00 Million | R$519.02 Million | R$392.62 Million |
| Goodwill | R$440.24 Million | R$440.24 Million | R$440.24 Million | R$440.24 Million | R$440.24 Million |
| Total Liabilities | R$4.03 Billion | R$3.40 Billion | R$2.85 Billion | R$2.56 Billion | R$2.33 Billion |
| Total Current Liabilities | R$2.99 Billion | R$2.45 Billion | R$1.96 Billion | R$1.72 Billion | R$1.54 Billion |
| Long-term Debt | R$551.18 Million | R$573.63 Million | R$532.65 Million | R$440.80 Million | R$433.64 Million |
| Net Debt | R$1.02 Billion | R$949.96 Million | R$840.94 Million | R$758.37 Million | R$528.93 Million |
| Total Stockholder Equity | R$1.30 Billion | R$1.25 Billion | R$1.19 Billion | R$1.09 Billion | R$1.05 Billion |
| Retained Earnings | R$686.89 Million | R$180.07 Million | R$156.97 Million | R$97.35 Million | R$52.33 Million |
Profarma Distribuidora de Produtos Farmacêuticos S.A Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Profarma Distribuidora de Produtos Farmacêuticos S.A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | R$497.09 Million | R$260.90 Million | R$126.32 Million | R$107.58 Million | R$39.34 Million |
| Capital Expenditures | R$28.05 Million | R$14.01 Million | R$10.51 Million | R$13.55 Million | R$36.04 Million |
| Free Cash Flow | R$469.03 Million | R$246.89 Million | R$115.81 Million | R$94.03 Million | R$3.30 Million |
| Investing Cash Flow | R$-136.84 Million | R$-96.58 Million | R$-21.74 Million | R$-86.41 Million | R$-47.75 Million |
| Financing Cash Flow | R$-324.44 Million | R$-153.83 Million | R$-109.84 Million | R$-204.44 Million | R$154.38 Million |
| Dividends Paid | R$54.58 Million | R$31.23 Million | — | R$29.12 Million | R$29.12 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | R$169.52 Million | R$148.52 Million | R$138.22 Million | R$125.89 Million | R$101.94 Million |
| Change in Cash | R$35.81 Million | R$10.49 Million | R$-5.26 Million | R$-183.28 Million | R$145.98 Million |
Profarma Distribuidora de Produtos Farmacêuticos S.A Earnings History — EPS Actual vs. Analyst Estimates
Track Profarma Distribuidora de Produtos Farmacêuticos S.A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 04, 2026 | — | — | — |
| Oct 29, 2025 | — | — | — |
| Jul 30, 2025 | — | — | — |
| May 05, 2025 | — | — | — |
| Aug 11, 2022 | 0.54 | — | — |
| May 11, 2022 | -0.05 | — | — |
| Mar 16, 2022 | 0.09 | — | — |
| Nov 10, 2021 | 0.20 | — | — |